العربية
Русский
Português
中文 (中国)
Türkçe
Spanish
Polski
Ελληνικά
Čeština
Norsk NynorskFuture of medicine
Enbiosis uses advanced AI and clinical science to transform the future
of healthcare by optimizing the gut microbiome.
Company timeline
2019
01
Enbiosis is established by professionals in science to bring clinically validated, AI-powered health solutions to market.
2020
02
Recognized by Bayer’s Program, confirming Enbiosis’ role as a high-potential innovator in precision health.
2021
03
Enbiosis expands operations and partnerships, reaching a company valuation, driven by increasing clinical adoption.
2022
04
Enbiosis gains international recognition through awards from Sanofi and the UK Government.
2023
05
Backed by strong clinical outcomes and commercial momentum, Enbiosis reaches a $9 million valuation.
2025
06
Enbiosis continues its international expansion, working with top-tier healthcare providers and delivering proven solutions to thousands of patients.
Vision & Mission
We envision a future in the 21st century where human lifespan could nearly double,
accompanied by prolonged health-span and sustained youthful vitality
Redefining
human longevity
Doubling lifespan. Sustaining vitality. Leading the future.
A new era of life
Driven by science. Delivered by Enbiosis.
Live longer.
Live stronger.
Enbiosis is pioneering the future of human health.
“We are building more than a company — we are building a future where health is at the center of human life.”
Ömer Özkan
CEO & Founder
“Artificial intelligence reveals insights from the microbiome that traditional science cannot see — opening a new era for human health.”
Ufuk Nalbantoğlu
Chief Technology Officer
Designing the future of longevity
Extended lifespan. Prolonged youth. Realized today.
Where science
meets vitality
Envisioning a world where health and youth last a lifetime.
Our impact in numbers
We’ve helped over 4,000 patients to date, using microbiome data to guide treatment decisions.
78%
Success in IBS treatment
(Gut Microbes, 2022)
(Gut Microbes, 2022)
83%
Success in treating chronic constipation
(Journal of Clinical Medicine, 2022)
(Journal of Clinical Medicine, 2022)
Enbiosis has been featured in major scientific publications, awarded internationally, and trusted by leading clinics and distributors.
Validated by the UK Government,
peer-reviewed journals, numerous business partners,
and thousands of patients.
peer-reviewed journals, numerous business partners,
and thousands of patients.
Published in peer-reviewed
journals
Tech Rocketship Winner /
UK’s #1 Tech Scale up
Trusted Globally: Enbiosis
in 20 Countries and Counting
Our partners
Our global partner network includes
Testimonials & video voices
Real results. Real people. Watch our partners and patients share their experiences with Enbiosis:
“Enbiosis enables me to offer patients something genuinely new: AI-powered, actionable insights based
on the gut microbiome.”
Dr. Nigel Beejay
Gastroenterologist, UAE & UK
“What impressed me the most is how much people’s symptoms improve with personalized nutrition. This is a revolution in patient care.”
Matthew Maloney
UK Health Coach, Certified Health & Nutrition Coach
“Enbiosis has opened a new dimension
in how we view personalized health through
AI and the microbiome.”
Jose Xavier Cobo
Fidelity, Ecuador
“Had much more to learn. Their approach changed my life.”
Dr. Nigel Beejay
Gastroenterologist, UAE & UK
“Years of GERD symptoms finally eased. This program gave me back my energy and balance.”
Heather Murata
Director of Communications, H6FIT (Kona, HI)
“Our collaboration with Enbiosis has added real value to our services and client satisfaction.”
Dr. Gulsen Meral
Assoc. Prof., Epigenetic Coaching UK
“I lost 11 pounds, normalized my blood pressure, and finally feel energized.”
Elif Yilmaz
Private Client (London, UK)
